• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
WLD
Click for more information
0.00% 6.6¢

WELLARD LIMITED - Charts / Financials

Market Cap $35.06M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Packaged Foods

Wellard Limited is an Australia-based supplier of livestock vessels and livestock. The... Wellard Limited is an Australia-based supplier of livestock vessels and livestock. The Company’s core business is chartering purpose-built, medium, and large livestock vessels to international exporters and importers who want their livestock to arrive at their destination fit and healthy. Its Chartering segment is engaged in the business of livestock transportation required to deliver livestock globally. Its Other segment consists of trading and corporate services. Trading refers to the business of livestock marketing, buying livestock from multiple sources for export to buyers in international markets globally. It also connects primary producers of cattle, sheep, and other livestock to customers globally. It designs and builds its own vessels to avoid the compromises in the design that retrofitting an existing ship requires. The Wellard fleet consists of MV Ocean Drover, and MV Ocean Ute. The MV Ocean Drover is a livestock carrier, with advanced ventilation, feed, and water systems.More

refresh Created with Sketch. REFRESH
Last update - 10.29am 02/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 6.3¢ 129949   1 6.6¢ 1187

Directors & Senior Management

Mr. John Walter Klepec Executive Chairman of the Board
Mr. Paolo Triglia Chief Financial Officer, Managing Director of Wellard Ships Pte Ltd
Mr. Michael Silbert General Counsel, Company Secretary
Mr. Kanda Lu Executive Director, Business Development Manager, China
Mr. Philip Clausius Non-Executive Independent Director
Mr. John Stevenson Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
6.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $35.06M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 129949 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 1187 1
View Market Depth
Last trade - 10.09am 02/10/2024 (20 minute delay) ?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.